Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-08-04
1994-09-27
Brust, Joseph Paul
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514375, 548153, 548218, C07D51304, C07D49804, A61K 3142, A61K 31425
Patent
active
053507606
ABSTRACT:
Compounds having the formula I: ##STR1## are antagonists of the actions of leukotrienes. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection.
REFERENCES:
patent: 4794188 (1988-12-01), Musser et al.
patent: 5037840 (1991-08-01), Young et al.
Belley Michel
Dufresne Claude
LaBelle Mark
Xiang Yibin
Brust Joseph Paul
Gabilan MarySusan H.
Merck Frosst Canada Inc.
North Robert J.
Winokur Melvin
LandOfFree
Aza-5,5-fused hetrocyclic acids as leukotriene antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aza-5,5-fused hetrocyclic acids as leukotriene antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aza-5,5-fused hetrocyclic acids as leukotriene antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1265683